Trademark: 79348988
Word
MEPSGEN
Status Date
Tuesday, June 18, 2024
Filing Date
Thursday, April 28, 2022
Published for Opposition
Tuesday, June 18, 2024
9 Biochips for research or scientific purposes; biochip analyzing apparatus, namely, electronic biochip inspection device for testing functionality of biochips; apparatus for inspecting biochips for laboratory use, namely, electronic biochip inspection device for testing functionality of biochips; apparatus for analyzing biochips for laboratory use, namely, electronic biochip analysis device for analyzing functionality of biochips; apparatus for manufacturing biochips for laboratory use, namely, electronic installations for the remote control of industrial biochip manufacturing operations; laboratory apparatus for analyzing biological pharmaceuticals, namely, laboratory analysis device for analyzing efficacy, potency, and toxicity evaluations of biological pharmaceuticals; microchips
5 Pharmaceutical products for treating respiratory diseases; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of central nervous system (CNS) diseases; stimulants for the central nervous system; pharmaceutical preparations for tumor treatment; tissue- regenerative pharmaceutical preparations; pharmaceutical preparations for use in tissue transplantation; clinical diagnostic reagents; clinical medical reagents; pharmaceuticals for the treatment of Parkinson's disease, Alzheimer's disease, Neurocognitive disorder, Neurodegenerative disease, Cancer, Brain disease; pharmaceutical compositions for treating Parkinson's disease, Alzheimer's disease, Neurocognitive disorder, Neurodegenerative disease, cancer, and brain disease; pharmaceutical drugs for treating Parkinson's disease, Alzheimer's disease, Neurocognitive disorder, Neurodegenerative disease, cancer, and brain disease; cells for medical purposes; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the prevention of inflammatory disorders; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the treatment of cardiovascular disease; cardiovascular pharmaceuticals; pharmaceutical preparations for the prevention of disorders of the nervous system; cardiovascular treatment preparations; cardiovascular pharmaceutical preparations; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for immunity adjustment; pharmaceutical agents affecting metabolism; pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical preparations for the prevention of diseases of the endocrine system; pharmaceutical products for the treatment of infectious diseases
35 Wholesale store services featuring cell growth media for growing cells for use in scientific research; retail store services featuring cell growth media for growing cells for use in scientific research; wholesale store services featuring biological preparation for use in cell cultures other than for medical or veterinary use; retail store services featuring biological preparation for use in cell cultures other than for medical or veterinary use; wholesale store services featuring pharmaceutical preparations for the treatment of cells; retail store services featuring pharmaceutical preparations for the treatment of cells; wholesale store services featuring cardiovascular pharmaceuticals; retail store services featuring cardiovascular pharmaceuticals; wholesale store services featuring chemico-pharmaceutical preparations; retail store services featuring chemico-pharmaceutical preparations; wholesale store services featuring medical instruments; retail store services featuring medical instruments; wholesale store services featuring medical apparatus and instruments; retail store services featuring medical apparatus and instruments; wholesale store services featuring biological preparations for medical or veterinary purposes; retail store services featuring biological preparations for medical or veterinary purposes; wholesale store services featuring biotechnological preparations for medical purposes; retail store services featuring biotechnological preparations for medical purposes; wholesale store services featuring biological reagents for medical purposes; retail store services featuring biological reagents for medical purposes; wholesale store services featuring biological tissue cultures for medical purposes; retail store services featuring biological tissue cultures for medical purposes; wholesale store services featuring biological preparations for medical purposes; retail store services featuring biological preparations for medical purposes; wholesale store services featuring living cells for medical purposes; retail store services featuring living cells for medical purposes; wholesale store services featuring cells for medical purposes; retail store services featuring cells for medical purposes; wholesale store services featuring cell culture instruments for medical use; retail store services featuring cell culture instruments for medical use; wholesale store services featuring cardiovascular agents for medical purposes; retail store services featuring cardiovascular agents for medical purposes; wholesale store services featuring drugs for medical purposes; retail store services featuring drugs for medical purposes; wholesale store services featuring stem cells for medical purposes; retail store services featuring stem cells for medical purposes; wholesale store services featuring chemical preparations for medical purposes; retail store services featuring chemical preparations for medical purposes
10 Medical diagnostic apparatus for the detection of cardiovascular diseases; medical apparatus and instruments for use in medical examination and treatment of cardiovascular diseases; cell culture instruments for medical use, namely, cell culture chambers
42 Crude medicines research; drug discovery services; development of cell therapy products; development of pharmaceutical preparations and medicines; laboratory research in the field of pharmaceuticals; pharmaceutical drug development; research on the subject of pharmaceuticals; scientific research in the field of pharmacy; medical studies in the nature of medical and scientific research, namely, conducting clinical trials for others, and translational research and medical and scientific research; scientific research services for medical purposes in the field of cancerous diseases, CNS diseases, and brain diseases; drug delivery, medicinal effect, Biological or biotechnological research for medical products; development of biotechnology, namely, medical drug and biochip products; biotechnology research; laboratory research in the field of biology; development of biologics, namely, vaccine and therapeutic drug products; research in the field of chemistry; technological studies in the nature of biotechnology and microfluidics research; research and development of medical equipment; development of medical devices; conducting clinical trials in the field of cardiovascular disease; conducting early efficacy, potency, and toxicity evaluations in the field of new pharmaceuticals; conducting early pharmaceutical product evaluations in the field of new pharmaceuticals; testing of pharmaceuticals; laboratory research services relating to pharmaceuticals; providing information on the testing, inspection, research of medical products; consultancy in the field of testing, inspection, and research of medical products, namely, pharmaceuticals, pharmaceutical preparations and pharmaceutical compositions; pharmaceutical product evaluation; design of devices for biological medicine analysis; development of devices for biological chemicals analysis; development of devices for biochemical chemicals; microchip design services
Sep 8, 2022
Sn Assigned For Sect 66a Appl From Ib
Sep 9, 2022
New Application Office Supplied Data Entered
Sep 13, 2022
Application Filing Receipt Mailed
Feb 16, 2023
Assigned To Examiner
Feb 24, 2023
Non-Final Action Written
Feb 25, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Apr 17, 2023
Refusal Processed By Mpu
Apr 17, 2023
Non-Final Action Mailed - Refusal Sent To Ib
May 10, 2023
Refusal Processed By Ib
Oct 17, 2023
Teas Response To Office Action Received
Oct 17, 2023
Correspondence Received In Law Office
Oct 18, 2023
Teas/Email Correspondence Entered
Nov 1, 2023
Assigned To Lie
Nov 14, 2023
Final Refusal E-Mailed
Nov 1, 2023
Data Modification Completed
Nov 14, 2023
Final Refusal Written
Nov 14, 2023
Notification Of Final Refusal Emailed
Feb 14, 2024
Notification Of Possible Opposition Sent To Ib
Feb 14, 2024
Notification Of Possible Opposition Created, To Be Sent To Ib
Mar 3, 2024
Notification Of Possible Opposition - Processed By Ib
Apr 29, 2024
Teas/Email Correspondence Entered
Apr 29, 2024
Correspondence Received In Law Office
Apr 29, 2024
Teas Request For Reconsideration Received
May 14, 2024
Exparte Appeal Received At Ttab
May 14, 2024
Jurisdiction Restored To Examining Attorney
May 14, 2024
Ex Parte Appeal-Instituted
May 16, 2024
Examiners Amendment -Written
May 16, 2024
Examiners Amendment E-Mailed
May 16, 2024
Exparte Appeal Terminated
May 16, 2024
Examiner's Amendment Entered
May 16, 2024
Notification Of Examiners Amendment E-Mailed
May 16, 2024
Approved For Pub - Principal Register
May 29, 2024
Notification Of Notice Of Publication E-Mailed
Jun 11, 2024
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jun 11, 2024
Notification Of Possible Opposition Sent To Ib
Jun 18, 2024
Published For Opposition
Jun 18, 2024
Official Gazette Publication Confirmation E-Mailed
Jul 1, 2024
Notification Processed By Ib
Trademark Alertz updated from USPTO on 2030-01-24
